Sign inJoin waitlistJoin the waitlist

Jeffrey Strawn

Vice Chair, Research · University of Cincinnati Medical Center Inc.

Credentials: · · ·

History

Research · University of Cincinnati Medical Center Inc.
Present
Cincinnati Children's Hospital Medical Center
Present
University of Cincinnati Medical Center Inc.
Present

Child and Adolescent Psychiatry
Cincinnati Children's Hospital Medical Center
2009–2010
Psychiatry
University of Cincinnati
2005–2009
University of Cincinnati College of Medicine

Research

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Clinical Pharmacology & Therapeutics · 2023 · 360 citations
Neuroleptic malignant syndrome
Case report · American Journal of Psychiatry · 2007 · First of 3 authors · Corresponding · 342 citations
The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation
Annals of Clinical Psychiatry · 2017 · Last of 9 authors · Corresponding · 330 citations

Melissa DelBello
66 papers
Caleb Adler
32 papers
Rodrigo Duran
28 papers
Steve Strakowski
24 papers
Paul Croarkin
22 papers
TG
Thomas Geracioti
18 papers
Brooks Keeshin
16 papers · 4 as a fellow
John Walkup
15 papers
Anna Wehry
11 papers · 2 as a resident
Eric Dobson
10 papers · 3 as a resident
Fabiano Nery
9 papers · 1 as a resident
DB
Dewleen Baker
8 papers

Grants

Center for Clinical and Translational Science and Training
National Center for Advancing Translational Sciences · UM1
PI · $10.6M · University of Cincinnati
2025–2032
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety
National Institute of Child Health and Human Development · R01
Contact PI · $2.9M · University of Cincinnati
2020–2027
Center for Clinical and Translational Science and Training
National Center for Advancing Translational Sciences · UL1
PI · $13.6M · University of Cincinnati
2015–2025
Estracellular Vesicles as Non-Invasive Predictors of Antidepressant Outcomes in Pediatric Anxiety
National Institute of Child Health and Human Development · R01
Contact PI · $2.4M · University of Cincinnati
2019–2025

Clinical trials

Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
Principal investigator · Recruiting · Phase 4
University of Cincinnati
2021–2026
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Principal investigator · Unknown · Phase 4
University of Cincinnati
2020–2025
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
Principal investigator · Unknown · Phase 4
University of Cincinnati
2020–2025
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
Principal investigator · Recruiting · Phase 4
University of Cincinnati
2019–2026